Skip to main content
SpringerLink
Log in

Ezetimibe may lead to paradoxical progression of atherosclerosis

  • Clinical study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. Taylor AJ, Villines TC, Stanek EJ.Paradoxical progression of atherosclerosis related to low-density lipoprotein reduction and exposure to ezetimibe. European Heart Journal: [7 pages], 7 May 2012. Available from: URL: http://dx.doi.org/10.1093/eurheartj/ehs105

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ezetimibe may lead to paradoxical progression of atherosclerosis. React. Wkly. 1406, 3 (2012). https://doi.org/10.2165/00128415-201214060-00005

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128415-201214060-00005

Keywords

Search

Navigation